logo-loader

Helix BioPharma Corp.

Receive alerts
Market:
TSX
Market Cap:
$175.21 m
Price
1.37 CAD
Change
0.00%
52 weeks high
1.50
52 weeks low
0.24

In brief

Helix BioPharma Corp. is an immuno-oncology company specializing in the field of cancer therapy. The company is actively developing innovative products for the prevention and treatment of cancer based on its proprietary technologies. Helix’s product development initiatives include its novel L-DOS47 new drug candidate and Chimeric Antigen Receptor (“CAR”) based cell therapies.